methsuximide has been researched along with TDP-43 Proteinopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barclay, JW; Berry, NG; Burgoyne, RD; Kraemer, BC; Morgan, A; O'Neill, PM; Phelan, MM; Pidathala, C; Pontifex, MG; Wong, SQ | 1 |
1 other study(ies) available for methsuximide and TDP-43 Proteinopathies
| Article | Year |
|---|---|
α-Methyl-α-phenylsuccinimide ameliorates neurodegeneration in a C. elegans model of TDP-43 proteinopathy.
Topics: Animals; Animals, Genetically Modified; Anticonvulsants; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Disease Models, Animal; Female; Male; Neurodegenerative Diseases; Succinimides; TDP-43 Proteinopathies | 2018 |